Stock Comparison
LLY vs PFE
Eli Lilly and Company and Pfizer Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.08T
$138.44B
P/E (TTM)
42.9
18.5
Forward P/E
31.1
8.2
Price/Sales
14.9
2.2
Price/Book
32.2
1.5
EV/EBITDA
28.8
11.0
Dividend Yield
0.55%
7.27%
Profitability
Net Margin
35.00%
11.80%
Operating Margin
49.40%
31.60%
Return on Equity
107.50%
8.31%
Return on Assets
20.70%
5.69%
Growth (YoY)
Revenue Growth
55.50%
5.40%
Earnings Growth
169.90%
-10.10%
Price & Risk
Beta
0.5
0.3
52-Week High
$1,215.76
$28.28
52-Week Low
$619.40
$21.97
Analyst Target
$1,222.62
$29.15
Compare LLY and PFE your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.